Former 510(k) Staff Director Takes Critical Look At FDA's Reform Plan

As FDA rolls out changes to its 510(k) review process, Heather Rosecrans, former director of the 510(k) program staff, and now on the industry side of the debate, is watching with keen interest and some trepidation.